ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Revvity Inc.

Revvity Inc. (0KHE)

76,35
0,00
(0,00%)
Geschlossen 10 Juli 5:30PM

Revvity Inc. (0KHE) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
76,35
( - )
Gebot
76,35
Fragen
76,35
Volumen
14
Durchschnittliches Volumen (3 Mio.)
US$ 1.431.708
Finanzvolumen
-
0,00 Tagesbereich 0,00
76,35 52-Wochen-Bereich 76,35
Marktkapitalisierung
Unternehmenswert
15,181B
Handelsende
76,35
Handelsbeginn
-
Letzte Trade
4
@
112.5
(O)
Letzter Handelszeitpunkt
VWAP
-
Erlöse (LTM)
2,9B
Nettogewinn (LTM)
239,68M
Ausgegebene Aktien
111.559.773
Streubesitz (%)
91,56%
Institutioneller Besitz (%)
105,04%
Dividendenrendite (LTM)
0,28 (0,29%)
Kurs-Gewinn-Verhältnis
54,46
Kurs-Umsatz-Verhältnis (KUV)
4,37
Gewinn pro Aktie (EPS)
2,1
Beta
1,09

Über Revvity Inc.

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early ... Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts. Mehr anzeigen

Sektor
-
Branche
-
Website
Hauptsitz
Waltham, United States
Gegründet
2026
Revvity Inc. is listed in the sector of the Londoner Börse with ticker 0KHE. The last closing price for Revvity was US$76,35. Over the last year, Revvity shares have traded in a share price range of US$ 76,35 to US$ 76,35.

Revvity currently has 111.559.773 shares in issue. The market capitalisation of Revvity is US$8,52 billion. Revvity has a price to earnings ratio (PE ratio) of 54.46.

0KHE Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260076.3576.3576.3516376.35DE
520076.3576.3576.3529976.35DE
1560076.3576.3576.35128976.35DE
2600076.3576.3576.35113976.35DE

0KHE - Frequently Asked Questions (FAQ)

What is the current Revvity Inc. share price?
The current share price of Revvity Inc. is US$ 76,35
How many Revvity Inc. shares are in issue?
Revvity Inc. has 111.559.773 shares in issue
What is the market cap of Revvity Inc.?
The market capitalisation of Revvity Inc. is USD 8,52B
What is the 1 year trading range for Revvity Inc. share price?
Revvity Inc. has traded in the range of US$ 76,35 to US$ 76,35 during the past year
What is the PE ratio of Revvity Inc.?
The price to earnings ratio of Revvity Inc. is 54,46
What is the cash to sales ratio of Revvity Inc.?
The cash to sales ratio of Revvity Inc. is 4,37
What is the registered address of Revvity Inc.?
The registered address for Revvity Inc. is 77 4th Avenue, Waltham, Massachusetts, 02451
What is the Revvity Inc. website address?
The website address for Revvity Inc. is www.revvity.com

0KHE Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen